Pharmaceutical Technology, Jul 2, 2011 - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Pharmaceutical Technology, Jul 2, 2011
Special Report
Calling the Shots: Innovation in Controlled-Release Injectables
By Erik Greb , Rich Whitworth
High demand could lead to innovation in controlled-release injectables.
The Power of Particle Characterization
By Stephanie Sutton
Pharma's drive for manufacturing efficiency is bolstering particle-characterization technologies.
Special Feature
Multiunit Particulate Systems: A Current Drug-Delivery Technology
By Mitesh D. Phale , Abhijit V. Gothoskar
The current review describes the role and selection of excipients, pellet core, coating materials, and compression with various cushioning agents.
FDA Introduces Spectral Library
By Lucinda Buhse , Philip H. Merrell
FDA, in cooperation with IPEC, is building a spectral library of excipients to detect improper ingredients within a drug product on site.
Quality Risk-Management Principles and PQRI Case Studies
By Ted Frank , Stephen Brooks , Kristin Murray , Steve Reich , Ed Sanchez , Brian Hasselbalch , Kwame Obeng , Richard Creekmore
A PQRI expert working group provides case study examples of risk-management applications.
PQRI Case Study (1): Defining Process Design Space
By Ted Frank , Stephen Brooks , Kristin Murray , Steve Reich , Ed Sanchez , Brian Hasselbalch , Kwame Obeng , Richard Creekmore
A PQRI expert working group provides case study examples of risk-management applications.
Peer-Reviewed Research
The Influence of Hydro-Alcoholic Media on Drug Release
By Dasha Palmer , Marina Levina , Thomas P. Farrell , Ali R. Rajabi-Siahboomi
The authors investigate the influence of hydro-alcoholic media on hydration and drug release from polyethylene oxide extended-release matrices.
From The Editor
Legislation v. Litigation
By Michelle Hoffman
Which route will we take to arrive at a national stem-cell policy?
PharmTech Talk
Pharma Leads in Sustainability
By Angie Drakulich
A new report places pharmaceutical and healthcare companies ahead in corporate and social governance.
Agent-in Place
All the Wrong Questions
By Control, a senior compliance officer
Getting an answer is easy—asking the right question is apparently more difficult.
Report from Europe
By Sean Milmo
Member states in the EU are working to implement the newly passed Falsified Medicines Directive.
Global Healthcare on the Ground: GlaxoSmithKline's Efforts
By Angie Drakulich
GSK Works in Developing Nations to Improve Everything from Research to Roads.
In the Spotlight
In the Spotlight
Editor's picks of new manufacturing products for July 2011.
Washington Report
FDA and Manufacturers Ponder Biosimilars Pathway
By Jill Wechsler
Follow-on versions of complex biologics require extensive expertise in development and regulatory procedures.
Biotech Financing Blues
By Tracy T. Lefteroff
The performance of biotechnology venture capital and investment is lackluster at best.
Pharma Ingredients
In Search of an Optimal Solid Form
By Patricia Van Arnum
The solid form of an API plays a crucial role in drug quality, and advancing methods for screening, detection, and characterization is key.
Formulation Development Forum: Controlled Agglomeration for Poorly Soluble Drugs
By Patricia Van Arnum
Pharmaceutical manufacturers look to various solutions to resolve the challenge of poorly soluble drugs
Outsourcing Outlook
Offsetting Budget Cuts
By Gregg Brandyberry
Better strategies and practices in sourcing and procurement can contribute to the bottom line.
Industry Leader
Q&A with Steve Strickland, Sensient
Steve Strickland, general manager of Sensient Pharmaceutical Coating Systems, on recent industry trends.
Regenerative Medicine: The Need for a National Strategy
By Elizabeth West
US support of regenerative medicine is essential for maintaining a lead on healthcare innovation.


LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
Click here